Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts
| dc.rights.license | open | en_US |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| hal.structure.identifier | Global Health in the Global South [GHiGS] | |
| dc.contributor.author | TIENDREBEOGO, Thierry | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| hal.structure.identifier | Global Health in the Global South [GHiGS] | |
| dc.contributor.author | MALATESTE, Karen | |
| dc.contributor.author | PODA, Armel | |
| dc.contributor.author | MINGA, Albert | |
| dc.contributor.author | MESSOU, Eugene | |
| dc.contributor.author | CHENAL, Henri | |
| dc.contributor.author | EZECHI, Oliver | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| hal.structure.identifier | Global Health in the Global South [GHiGS] | |
| dc.contributor.author | EKOUEVI, Didier Koumavi | |
| dc.contributor.author | OFOTOKUN, Igho | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| hal.structure.identifier | Global Health in the Global South [GHiGS] | |
| dc.contributor.author | JAQUET, Antoine | |
| dc.date.accessioned | 2024-06-26T11:29:51Z | |
| dc.date.available | 2024-06-26T11:29:51Z | |
| dc.date.issued | 2024-05-01 | |
| dc.identifier.issn | 2328-8957 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/200655 | |
| dc.description.abstractEn | Transition to dolutegravir among 21 167 individuals experienced in antiretroviral therapy in West Africa showed heterogeneous timelines and patterns. Initially reported sex disparities tended to catch up over time with persisting disparities, according to contributing HIV clinics. Key factors facilitating dolutegravir switch were male sex, age <50 years, viral suppression, and regimens not based on protease inhibitors. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.subject.en | HIV | |
| dc.subject.en | West Africa | |
| dc.subject.en | Dolutegravir | |
| dc.subject.en | Sex disparities | |
| dc.subject.en | Switch | |
| dc.title.en | Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts | |
| dc.title.alternative | Open Forum Infect Dis | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1093/ofid/ofae139 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 38680609 | en_US |
| bordeaux.journal | Open Forum Infectious Diseases | en_US |
| bordeaux.page | ofae139 | en_US |
| bordeaux.volume | 11 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.issue | 5 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | GHIGS_BPH | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Institut de Recherche pour le Développement | en_US |
| bordeaux.identifier.funderID | National Institutes of Health | en_US |
| hal.identifier | hal-04625804 | |
| hal.version | 1 | |
| hal.date.transferred | 2024-06-26T11:33:51Z | |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Open%20Forum%20Infectious%20Diseases&rft.date=2024-05-01&rft.volume=11&rft.issue=5&rft.spage=ofae139&rft.epage=ofae139&rft.eissn=2328-8957&rft.issn=2328-8957&rft.au=TIENDREBEOGO,%20Thierry&MALATESTE,%20Karen&PODA,%20Armel&MINGA,%20Albert&MESSOU,%20Eugene&rft.genre=article |
